St. Nicholas Private Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Sell
3,644
-140
-4% -$16.4K 0.41% 31
2026
Q1
$455K Sell
3,784
-10
-0.3% -$1.15K 0.43% 30
2025
Q4
$399K Sell
3,794
-1,487
-28% -$140K 0.36% 30
2025
Q3
$443K Hold
5,281
0.38% 30
2025
Q2
$418K Sell
5,281
-1
-0% -$79 0.39% 30
2025
Q1
$474K Sell
5,282
-615
-10% -$57.4K 0.45% 32
2024
Q4
$587K Buy
+5,897
New +$608K 0.52% 31

Other funds holding MRK

St. Nicholas Private Asset Management's MRK Position: Q2 2026 in Review

St. Nicholas Private Asset Management reduced its Merck (MRK) stake by 3.7% in Q2 2026, selling an estimated $16.4K and leaving 3,644 shares worth $468K. The position accounts for 0.41% of the portfolio, ranked #31.

St. Nicholas Private Asset Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $587K in Q4 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • St. Nicholas Private Asset Management held 3,644 shares of Merck worth $468K as of Q2 2026.
  • St. Nicholas Private Asset Management sold 140 Merck shares in Q2 2026, an estimated $16.4K.
  • Merck made up 0.41% of St. Nicholas Private Asset Management's portfolio in Q2 2026, its #31 holding.
  • St. Nicholas Private Asset Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • St. Nicholas Private Asset Management's Merck position peaked at $587K in Q4 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on St. Nicholas Private Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.